CYTEIR THERAPEUTICS
Live / Registered — Registered (as of 05 Oct 2021)
What this means for you
Registered since 05 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88982019
- Registration number
- 6512467
- Mark type
- Design + words
- Filed
- 11 Jul 2019
- Published for opposition
- 25 Feb 2020
- Registered
- 05 Oct 2021
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of cancer and autoimmune diseases; pharmaceutical preparations for use in oncology, hematology, and immunology; synthetic lethal therapies for inducing destruction of diseased cells with DNA damage for medical treatment purposes
Owner
- Cyteir Therapeutics, Inc., Lexington, MA, US
- Cyteir Therapeutics, Inc., Lexington, MA, US
- Cyteir Therapeutics, Inc., Lexington, MA, US
Prosecution history
- 05 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 31 Aug 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Aug 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Jun 2021 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 15 Jun 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Mar 2021 — USE AMENDMENT FILED
- 15 Jun 2021 — DIVISIONAL PROCESSING COMPLETE
- 01 Mar 2021 — DIVISIONAL REQUEST RECEIVED
- 14 Jun 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Mar 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Mar 2021 — TEAS REQUEST TO DIVIDE RECEIVED
- 01 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 22 Sept 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2020 — SOU EXTENSION 1 GRANTED
- 18 Sept 2020 — SOU EXTENSION 1 FILED